Strategies of Journal of Clinical Trials
The Journal of Clinical Trials aims to disseminate knowledge and promote discussion through the publication of peer-reviewed, high quality research papers on all topics related to Clinical Evaluations. The open access journal is published by OMICS International who hosts around 350 open access peer-reviewed journals as well as organizes more than 100 International scientific Conferences.
The Journal is successfully running in the 9th Volume which covers a wide variety of specialties including Cancer Surgery, Ovarian cancer, hepatitis infection, reaching out to analytical scientists worldwide. The Journal emphasizes high-level research and education. Original research articles, reviews, short communications, and letters to the editors in the fields of clinical trials are welcome. Every effort is made to have a speedy and critical peer-review process.
A clinical trial involves the healthy people and cancer patients to test safety and efficacy of newly developed cancer drugs. Clinical trials are conducted for new effective medications. Clinical trials are conducted at different cancer hospitals. These studies help in diagnosing and treatment of cancer. A cancer clinical trial can also be said to be as a cancer clinical study.
Benefits on Publication:
Permanent free access to your article upon publication ensures extensive global reach and readership. Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author. Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field. In a world of black & white journal articles, high-quality full-color images make your article stand out from the crowd and tell a complete story, increasing readers and citations. Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.
How we work:
After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days. A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted. Author proof is generated within 7 working days after the acceptance decision.
Thanks & Regards,
Journal of Clinical Trials